Research Papers

25 of 32 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to c…
Zareian N; Eremin O; Pandha H; Baird R; Kwatra V; Funingana G; Verma C; Choy D; Hargreaves S; Moghimi P; Shepherd A; Lobo DN; Eremin J; Farzaneh F; Kordasti S; Spicer J.
Exp Biol Med (Maywood) (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
A robust class decomposition-based approach for detecting Alzheimer's progression.
Alwuthaynani MM; Abdallah ZS; Santos-Rodriguez R.
Exp Biol Med (Maywood) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oral microbiota in human health and disease: A perspective.
Santacroce L; Passarelli PC; Azzolino D; Bottalico L; Charitos IA; Cazzolla AP; Colella M; Topi S; Godoy FG; D'Addona A.
Exp Biol Med (Maywood) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive value of serum HIF-1α and VEGF for arrhythmia in acute coronary syndrome patients.
Li B; Feng Q; Yu C; Yang J; Qin X; Li X; Cao J; Xu X; Yang C; Jin Y.
Exp Biol Med (Maywood) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Evaluation methodology for deep learning imputation models.
Boursalie O; Samavi R; Doyle TE.
Exp Biol Med (Maywood) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Weakly supervised learning and interpretability for endometrial whole slide image diagnosis.
Mohammadi M; Cooper J; Arandelović O; Fell C; Morrison D; Syed S; Konanahalli P; Bell S; Bryson G; Harrison DJ; Harris-Birtill D.
Exp Biol Med (Maywood) (Unknown)
Published: 2022
5/6 Transparent
Data Code Funding Declared
Antiviral activity of medicinal plant-derived products against SARS-CoV-2.
de Oliveira JR; Antunes BS; do Nascimento GO; Kawall JCS; Oliveira JVB; Silva KGDS; Costa MAT; Oliveira CR.
Exp Biol Med (Maywood) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Returning to basic principles to develop more effective treatments for central nervous system disorders.
Wexler BE.
Exp Biol Med (Maywood) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The multifunctionality of expression systems in <i>Bacillus subtilis</i>: Emerging devices for the production of recomb…
Souza CC; Guimarães JM; Pereira SDS; Mariúba LAM.
Exp Biol Med (Maywood) (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil.
Gasparini MS; Dos Santos LM; Hamade AM; Gross LG; Favarato AP; de Vasconcellos JP; de Melo MB; Parise PL; Simeoni CL; Silva NB; da Silva Mori MA; Vieira AS; Dos Santos Farias A; Granja F; Schreiber AZ; Moretti ML; Proença-Modena JL; Alves M.
Exp Biol Med (Maywood) (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.
Banerjee A; Mukherjee S; Maji BK.
Exp Biol Med (Maywood) (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Variable number tandem repeats - Their emerging role in sickness and health.
Marshall JN; Lopez AI; Pfaff AL; Koks S; Quinn JP; Bubb VJ.
Exp Biol Med (Maywood) (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
COVID-19 global pandemic planning: Dry heat incubation and ambient temperature fail to consistently inactivate SARS-CoV…
Perkins DJ; Nofchissey RA; Ye C; Donart N; Kell A; Foo-Hurwitz I; Muller T; Bradfute SB.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
COVID-19 global pandemic planning: Performance and electret charge of N95 respirators after recommended decontamination…
Grillet AM; Nemer MB; Storch S; Sanchez AL; Piekos ES; Leonard J; Hurwitz I; Perkins DJ.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Protease-activated receptor 1 as a potential therapeutic target for COVID-19.
Rovai ES; Alves T; Holzhausen M.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
A mini-review on the effects of COVID-19 on younger individuals.
Manivannan M; Jogalekar MP; Kavitha MS; Maran BAV; Gangadaran P.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects.
Dame K; Ribeiro AJ.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Is periodontal disease a risk factor for developing severe Covid-19 infection? The potential role of Galectin-3.
Kara C; Çelen K; Dede FÖ; Gökmenoğlu C; Kara NB.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Direct on-the-spot detection of SARS-CoV-2 in patients.
Ben-Assa N; Naddaf R; Gefen T; Capucha T; Hajjo H; Mandelbaum N; Elbaum L; Rogov P; King DA; Kaplan S; Rotem A; Chowers M; Szwarcwort-Cohen M; Paul M; Geva-Zatorsky N.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
COVID-19 global pandemic planning: Decontamination and reuse processes for N95 respirators.
Perkins DJ; Villescas S; Wu TH; Muller T; Bradfute S; Hurwitz I; Cheng Q; Wilcox H; Weiss M; Bartlett C; Langsjoen J; Seidenberg P.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
The <i>WWOX</i> gene in brain development and pathology.
Kośla K; Kałuzińska Ż; Bednarek AK.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar MP; Veerabathini A; Gangadaran P.
Exp Biol Med (Maywood) (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease.
Matlahov I; van der Wel PC.
Exp Biol Med (Maywood) (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Progress in synthesizing protocells.
Toparlak OD; Mansy SS.
Exp Biol Med (Maywood) (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Towards feedback-controlled nanomedicines for smart, adaptive delivery.
Jones SJ; Taylor AF; Beales PA.
Exp Biol Med (Maywood) (Unknown)
Published: 2018
2/6 Transparent
Funding Declared